Radiotracer dose reduction in integrated PET/MR: implications from national electrical manufacturers association

Mark Oehmigen1, Susanne Ziegler2, Bjoern W Jakoby3

  • 1Institute of Medical Physics, University of Erlangen-Nuremberg, Erlangen, Germany Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Essen, Germany High Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany mark.oehmigen@uni-due.de.

Abstract

Insights

Integrated PET/MR imaging can reduce radiotracer dose by increasing acquisition time, maintaining PET image quality. This study confirms that longer PET scan times compensate for lower activity, enabling dose reduction in clinical settings.

Area of Science:

  • Medical Imaging
  • Nuclear Medicine
  • Radiochemistry

Background:

  • Integrated Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging offers potential radiation dose reduction compared to PET/Computed Tomography (PET/CT).
  • Increasing PET acquisition duration in PET/MR may further reduce radiotracer dose while preserving image quality (IQ).

Purpose of the Study:

  • To systematically verify the hypothesis that increased PET acquisition time can compensate for reduced radiotracer activity in integrated PET/MR, maintaining PET IQ.
  • To establish a basis for clinical studies investigating reduced radiotracer doses in PET/MR.

Main Methods:

  • Utilized an integrated PET/MR whole-body system and a standardized National Electrical Manufacturers Association (NEMA) IQ phantom.
  • Acquired multiple PET data blocks with varying durations (2, 4, 8, 16 min) using (18)F-FDG, with decreasing activity levels compensated by increased acquisition time.
  • Quantitatively evaluated PET images for contrast recovery, background variability, and signal-to-noise ratio, repeating experiments for statistical robustness.

Main Results:

  • Contrast recovery, background variability, and signal-to-noise ratio remained consistent across different radiotracer activities and acquisition times.
  • Minor variations (mean 2% for contrast recovery, 5% for SNR) were observed, with no significant subjective difference in IQ detected by readers.
  • The study demonstrated that longer acquisition times effectively compensated for reduced activity, maintaining PET image quality.

Conclusions:

  • An approach to reduce injected radiotracer activity in integrated PET/MR imaging while maintaining PET IQ was successfully verified under controlled conditions.
  • This method provides a foundation for future clinical PET/MR studies aiming to lower radiotracer doses compared to conventional PET/CT.
  • The findings support the feasibility of dose reduction strategies in PET/MR through optimized acquisition protocols.

Related Concept Videos